Omada Health (OMDA) vs Strata Critical Medical (SRTA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Strata Critical Medical (SRTA) has outperformed Omada Health (OMDA) over the past year, gaining 8.6% versus a loss of 36.2%. Omada Health is the larger company by market cap ($736.4 million vs $407.3 million), about 1.8 times the size. Strata Critical Medical converts more of its revenue into profit, with a net margin of 21.0% versus -4.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OMDA | SRTA |
|---|---|---|
| Share price | $11.87 | $4.56 |
| Market cap | $736.39M | $407.30M |
| 1-day change | -5.04% | -5.59% |
| YTD return | -24.78% | -5.20% |
| 1-year return | -36.18% | +8.57% |
| 5-year return | — | -46.79% |
| P/E ratio (TTM) | 29.68 | — |
| Forward P/E | 17.18 | — |
| EPS (TTM) | $0.40 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $260.21M | $197.14M |
| Revenue growth (YoY) | +53.24% | +34.28% |
| Net income (latest FY) | $-12.78M | $41.35M |
| Gross margin | 65.69% | 20.86% |
| Operating margin | -4.60% | -11.34% |
| Net margin | -4.91% | 20.97% |
| 52-week high | $25.45 | $6.50 |
| 52-week low | $10.28 | $3.95 |
| Distance from 52-week high | -53.36% | -29.85% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +123.25% | +111.18% |
| Average volume | 1.33M | 982.75K |
| Shares outstanding | 62.04M | 89.32M |
| Employees | 980 | 327 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SRTA has outperformed OMDA by 44.8 percentage points over the past year.
- Strata Critical Medical is more profitable, keeping 21.0 cents of every revenue dollar as net income versus -4.9 cents for Omada Health.
- Omada Health grew revenue faster in its latest fiscal year (+53.24% vs +34.28%).
About Omada Health
OMDA stock →Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.
Health Care · Medical/Nursing Services · 980 employees
About Strata Critical Medical
SRTA stock →Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States.
Health Care · Medical/Nursing Services · 327 employees
OMDA vs SRTA FAQ
Which is bigger, Omada Health or Strata Critical Medical?
Omada Health (OMDA) is larger, with a market capitalization of $736.39M compared with $407.30M for Strata Critical Medical (SRTA).
Which stock has performed better over the past year, OMDA or SRTA?
SRTA returned +8.57% over the past 12 months, compared with -36.18% for OMDA (price return, excluding dividends). Past performance does not predict future results.
Are Omada Health and Strata Critical Medical in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.